Irkec, C. Et Al. 2017. Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet's disease. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , (Paris, France), 781-782.

Irkec, C., Kuz, T., Altiparmak, T., & Fidan, I., (2017). Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet's disease . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) (pp.781-782). Paris, France

Irkec, C. Et Al. "Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet's disease," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 2017

Irkec, C. Et Al. "Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet's disease." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.781-782, 2017

Irkec, C. Et Al. (2017) . "Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet's disease." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.781-782.

@conferencepaper{conferencepaper, author={C. Irkec Et Al. }, title={Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet's disease}, congress name={7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)}, city={Paris}, country={France}, year={2017}, pages={781-782} }